A wave of disease management programs are forming as companies seek ways to build relationships with physicians and patients.

“Pharmaceutical Patient Compliance and Disease Management,” a ground-breaking report from Cutting Edge Information (www.pharmadiseasemanagement.com), takes a critical and analytical look at several forward-thinking pharmaceutical companies’ efforts to maximize customers’ lifetime value through long-term relationship building. 

Eric Bolesh, lead analyst for the report, stressed the importance of compliance and disease management as a major extension of marketing.  “Customer outreach initiatives like disease management programs can push a marketing team beyond brand recognition and customer acquisition to something that drives ongoing customer dialogue and retention,” Bolesh said. 

Companies profiled in the report include pharmaceutical leaders such as Merck, Aventis and GlaxoSmithKline, as well as customer-pleasers such as FedEx and IBM.    The report also offers Cutting Edge Information’s principles for success in this area, including how to cultivate relationships with non-chronic consumers through health management resources. 

To download a summary of the 110-page report, “Pharmaceutical Patient Compliance and Disease Management,” visit http://www.PharmaDiseaseManagement.com . 

For more information or to learn about other research being conducted by Cutting Edge Information, contact Diana Borja at diana_borja@cuttingedgeinfo.com or 919-433-0219. 

 
<-- Back to the News Page

<-- Back to the Cutting Edge Information home page